Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of Strategies for Switching Patients From Amitriptyline to Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain

NCT00266643 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00266643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00266643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of Strategies for Switching Patients From Amitriptyline to Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2005
Completion date
April 30, 2007
Enrollment
205
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathy, painful